• Latest Posts

Bayer Launches Plant Microbiome Biotech with a Huge €84M Series A

A Swedish-Spanish Team Takes on a New Immuno-Oncology Target

Italian Biotech Closes €7M Series B for Stem Cells to Treat Cancer

Epigenetics Drug Proves Effective in Phase I for Lethal Cancer

Series D Boost will Bring Artificial Intelligence to Diagnostics Worldwide

What You Need to Know About the EU’s New Data Protection Law

ADVERTISEMENT

France Invests €15M in Developing a New Generation of Antibiotics

Norwegian Biotech Announces Positive Phase I Results for T cell-Stimulating Vaccine

British Biotech Receives €52M Boost To Beat Antimicrobial Resistance with New Antibiotic

French Nanoparticle Therapy Fails to Improve Liver Cancer Treatment in Phase III

French Startup Raises €11M in Series A to Reinvent DNA Synthesis

UPDATE: AstraZeneca’s Checkpoint Inhibitor Could be a Lung Cancer Blockbuster

ADVERTISEMENT